Related Experiment Video
Updated: Nov 13, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Increased Carotid Intima-Media Thickness and Endothelial Cell-Specific Molecule-1 (Endocan) Levels in Obese Children
Ayşin Nalbantoğlu1, Özgür Kızılca2, Savaş Güzel3
1Faculty of Medicine, Department of Pediatrics, 472605Namık Kemal University, Tekirdağ, Turkey.
Insights
Childhood obesity is linked to future heart disease. Elevated endocan and carotid intima-media thickness (cIMT) in obese children may signal endothelial damage, suggesting potential biomarkers for early intervention.
Area of Science:
- Pediatric Endocrinology
- Cardiovascular Health
- Metabolic Disease Research
Background:
- Childhood obesity increases the risk of adult cardiovascular and metabolic diseases.
- Early insulin resistance (IR) can cause endothelial dysfunction and increased carotid intima-media thickness (cIMT) in children.
- Endothelial cell-specific molecule-1 (endocan) is a potential marker for endothelial damage.
Purpose of the Study:
- To compare endocan levels in obese children versus healthy controls.
- To investigate endocan as a potential biomarker for endothelial damage complications in pediatric obesity.
- To assess the relationship between cIMT, insulin resistance, and endocan levels in obese children.
Main Methods:
- Study included 80 obese pubertal children and 80 healthy pubertal controls.
- Evaluated anthropometric measurements, cIMT (via high-resolution ultrasound), endocan levels, and HOMA-IR.
- Compared these parameters between obese and control groups.
Main Results:
- Obese children exhibited significantly higher endocan levels, fasting insulin, HOMA-IR, and cIMT compared to controls (P < .001 for all).
- A significant correlation was found between cIMT and HOMA-IR (β = -1.314, P = .002) in obese children.
- A significant correlation was observed between cIMT and endocan levels (β = .483, P = .004) in obese children.
Conclusions:
- Endocan levels are elevated in obese children, suggesting it may serve as a biomarker for endothelial damage.
- Increased cIMT and HOMA-IR in obese children indicate early cardiovascular and metabolic risks.
- Noninvasive measurement of cIMT and endocan in obese children can aid early preventive strategies to reduce adult morbidity and mortality.
Abstract:
Obesity in children appears to be associated with increased risk of cardiovascular and metabolic diseases later in life. Early development of insulin resistance (IR) may lead to endothelial dysfunction and increased carotid intima-media thickness (cIMT) even in childhood. We compared endothelial cell-specific molecule-1 (endocan) levels in pediatric obese patients with those in healthy controls to determine whether endocan could be used as a biological marker of complications caused by endothelial damage. In 80 obese pubertal children (44 males [M] and 36 females [F], mean age: 12.8 ± 2.5 years), anthropometric measurements, cIMT, endocan levels, and IR indices (homeostasis model assessment of insulin resistance [HOMA-IR]) were evaluated and compared with 80 healthy pubertal patients (42M/38F, mean age: 12.3 ± 3.2 years). High-resolution ultrasound was used to measure the cIMT. Obese children had higher levels of endocan compared with the controls (P < .001). Fasting insulin levels and HOMA-IR were also higher in obese children (P < .001 for both). In addition, obese children had an increased cIMT (P < .001). In obese children, there was a significant correlation between cIMT and HOMA-IR (β = -1.314, P = .002) and between cIMT and endocan (β = .483, P = .004). Measuring cIMT and endocan levels (noninvasive investigations) in obese children, together with early preventive measures, could significantly decrease morbidity and mortality in adulthood.
Related Concept Videos
Obesity
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Coronary Artery Disease II: Pathophysiology
Atherosclerosis III: Management

